NCT06815731 Multicenter Study on the Correction of Prolapse Via Laparoscopy
| NCT ID | NCT06815731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia |
| Condition | Pelvic Floor Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 181 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 181 participants in total. It began in 2023-10-01 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the laparoscopic lateral suspension (LLS) technique, the fixation of the mesh as a prosthetic element for correcting anterior apical vaginal prolapse at the level of the dome or uterus can offer anatomical and functional results that are not inferior to those of the conventional surgical technique, minimize possible intraoperative complications and facilitate the specific learning curve of sacropexy.
Eligibility Criteria
Inclusion Criteria: * Patients with Stage II- IV primary or recurrent prolapse affecting the anterior or middle vaginal compartment with or without minimal posterior defect (Stage I) according to the POP-Q. Exclusion Criteria: * History of abdominal prolapse reconstructive surgery. * History of prolapse reconstructive surgery with vaginal meshes. * Stage I according to the POP-Q classification or asymptomatic prolapse. * Medical contraindication for general anaesthesia. * Patient preference for vaginal surgical treatment. * Patient does not wish to participate in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06815731 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pelvic Floor Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06815731 currently recruiting?
Yes, NCT06815731 is actively recruiting participants. Contact the research team at marisasanchezferrer1@gmail.com for enrollment information.
Where is the NCT06815731 trial being conducted?
This trial is being conducted at Murcia, Spain.
Who is sponsoring the NCT06815731 clinical trial?
NCT06815731 is sponsored by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. The trial plans to enroll 181 participants.